We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.93B
AUM Growth
+$1.15B
Cap. Flow
+$1.17B
Cap. Flow %
23.66%
Top 10 Hldgs %
15.43%
Holding
758
New
275
Increased
122
Reduced
113
Closed
194

Top Sells

Rank Stock Value
1
CUZ icon
Cousins Properties
CUZ
+$87.3M
2
VICI icon
VICI Properties
VICI
+$58.6M
3
VTR icon
Ventas
VTR
+$50.3M
4
BXP icon
Boston Properties
BXP
+$39.8M
5
COLD icon
Americold
COLD
+$34.5M

Sector Composition

Rank Sector Weight
1 Real Estate 18.43%
2 Technology 10.03%
3 Industrials 7.7%
4 Healthcare 6.67%
5 Energy 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNDT icon
476
CALL
Conduent
CNDT
$251M
$627K 0.01%
100,800
+50,800
+102% +$393K
KALV
477
DELISTED
KalVista Pharmaceuticals
KALV
$626K 0.01%
54,000
AUTL
478
Autolus Therapeutics
AUTL
$386M
$621K 0.01%
50,000
SRPT icon
479
Sarepta Therapeutics
SRPT
$1.63B
$603K 0.01%
8,000
+3,000
+60% +$354K
IONS icon
480
Ionis Pharmaceuticals
IONS
$9.14B
$599K 0.01%
10,000
ALDR
481
DELISTED
Alder Biopharmaceuticals
ALDR
$595K 0.01%
+31,526
New +$361K
NSTG
482
DELISTED
NanoString Technologies, Inc.
NSTG
$561K 0.01%
26,000
+1,000
+4% +$26.5K
REGN icon
483
Regeneron Pharmaceuticals
REGN
$72.9B
$555K 0.01%
+2,000
New +$592K
AFG icon
484
American Financial Group
AFG
$12B
$550K 0.01%
5,098
-139,902
-96% -$14.5M
GNMK
485
DELISTED
GenMark Diagnostics, Inc
GNMK
$545K 0.01%
90,000
-20,000
-18% -$125K
MRUS
486
DELISTED
Merus
MRUS
$535K 0.01%
30,000
TXMD icon
487
TherapeuticsMD
TXMD
$23.8M
$530K 0.01%
2,920
+220
+8% +$31K
NTNX icon
488
Nutanix
NTNX
$16B
$525K 0.01%
+19,999
New +$471K
MYOK
489
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$522K 0.01%
10,000
-10,000
-50% -$532K
PING
490
DELISTED
Ping Identity Holding Corp.
PING
$518K 0.01%
+30,000
New +$546K
STAA icon
491
STAAR Surgical
STAA
$1.13B
$516K 0.01%
20,000
-7,500
-27% -$228K
ARQL
492
DELISTED
Arqule Inc
ARQL
$509K 0.01%
71,000
+31,000
+78% +$291K
CNR
493
Core Natural Resources Inc
CNR
$4.02B
$492K 0.01%
31,499
ALXN
494
DELISTED
Alexion Pharmaceuticals
ALXN
$490K 0.01%
5,000
GBT
495
DELISTED
Global Blood Therapeutics, Inc.
GBT
$485K 0.01%
10,000
-5,000
-33% -$261K
CSII
496
DELISTED
Cardiovascular Systems, Inc.
CSII
$475K 0.01%
10,000
PACB icon
497
Pacific Biosciences
PACB
$432M
$464K 0.01%
+90,000
New +$503K
LAB icon
498
Standard BioTools
LAB
$311M
$463K 0.01%
100,000
-10,000
-9% -$78.8K
HZNP
499
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$463K 0.01%
17,000
VIAB
500
DELISTED
Viacom Inc. Class B
VIAB
$454K 0.01%
+18,875
New +$527K

Similar funds

Weiss Multi-Strategy Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, Weiss Multi-Strategy Advisers held 758 positions worth $4.93B, up 30% from $3.78B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Weiss Multi-Strategy Advisers deployed $1.17B of net new capital in Q3 2019, opening 275 new positions and adding to 122 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was VICI Properties, an estimated $58.6M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q3 2019 buy was Zayo Group Holdings, Inc.: 2,371,034 shares worth $80.4M.
  • Weiss Multi-Strategy Advisers added most to Celgene Corp in Q3 2019, an estimated $106M increase.
  • Weiss Multi-Strategy Advisers's biggest Q3 2019 reduction was VICI Properties, cutting an estimated $58.6M.
  • Weiss Multi-Strategy Advisers fully exited Cousins Properties in Q3 2019, selling an estimated $87.3M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 15% of its $4.93B portfolio in Q3 2019.
  • Weiss Multi-Strategy Advisers opened 275 new positions and closed 194 in Q3 2019.
  • Weiss Multi-Strategy Advisers's portfolio value rose 30% quarter-over-quarter to $4.93B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.